The Effect of Intra-articular Corticosteroids on Articular Cartilage: A Systematic Review

Chloe Wernecke, Hillary J Braun, Jason L Dragoo, Chloe Wernecke, Hillary J Braun, Jason L Dragoo

Abstract

Background: Intra-articular (IA) corticosteroid therapy has been used for the treatment of inflammation and pain in the knee since the 1950s.

Purpose: To review the current literature on the effects of IA corticosteroids on articular cartilage.

Study design: Systematic review.

Methods: A MEDLINE and SCOPUS database search was performed, and studies were selected for basic science and clinical trial research on corticosteroids with direct outcome measures of cartilage health. Preliminary searches yielded 1929 articles, and final analysis includes 40 studies.

Results: Methylprednisolone, dexamethasone, hydrocortisone, betamethasone, prednisolone, and triamcinolone were reported to display dose-dependent deleterious effects on cartilage morphology, histology, and viability in both in vitro and in vivo models. The beneficial animal in vivo effects of methylprednisolone, hydrocortisone, and triamcinolone occurred at low doses (usually <2-3 mg/dose or 8-12 mg/cumulative total dose in vivo), at which increased cell growth and recovery from damage was observed; the single human clinical trial indicated a beneficial effect of triamcinolone. However, at higher doses (>3 mg/dose or 18-24 mg/cumulative total dose in vivo), corticosteroids were associated with significant gross cartilage damage and chondrocyte toxicity. Dose and time dependency of corticosteroid chondrotoxicity was supported in the in vitro results, however, without clear dose thresholds.

Conclusion: Corticosteroids have a time- and dose-dependent effect on articular cartilage, with beneficial effects occurring at low doses and durations and detrimental effects at high doses and durations. Clinically, beneficial effects are supported for IA administration, but the lowest efficacious dose should be used.

Keywords: articular cartilage; betamethasone; chondrocytes; corticosteroid; dexamethasone; hydrocortisone; methylprednisolone; prednisolone; triamcinolone.

Conflict of interest statement

The authors reported that they have no conflicts of interest in the authorship and publication of this contribution.

Figures

Figure 1.
Figure 1.
PRISMA flow diagram.

References

    1. Albano MB, Skroch GP, Ioshii SO, Grahels XS, de Alencar PG, Matias JE. Computerized photocolorimetric analysis of the effects of intraarticular betamethasone on the proteoglycan concentration of leporine knee cartilage matrix: influence of the number of intraarticular injections. Rev Col Bras Cir. 2009;36:256–260.
    1. Badurski JE, Schwamm W, Popko J, Zimnoch L, Rogowski F, Pawlica J. Chondroprotective action of salmon calcitonin in experimental arthropathies. Calcif Tissue Int. 1991;49:27–34.
    1. Barker WD, Martinek J. An ultrastructural evaluation of the effect of hydrocortisone on rabbit cartilage. Clin Orthop Relat Res. 1976;(115):286–290.
    1. Behrens F, Shepard N, Mitchell N. Alterations of rabbit articular cartilage by intra-articular injections of glucocorticoids. J Bone Joint Surg Am. 1975;57:70–76.
    1. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;(2):CD005328.
    1. Caldwell JR. Intra-articular corticosteroids. Guide to selection and indications for use. Drugs. 1996;52:507–514.
    1. Chu SC, Yang SF, Lue KH, Hsieh YS, Li TJ, Lu KH. Naproxen, meloxicam and methylprednisolone inhibit urokinase plasminogen activator and inhibitor and gelatinases expression during the early stage of osteoarthritis. Clin Chim Acta. 2008;387:90–96.
    1. Davis D, Cyriac M, Ge D, You Z, Savoie FH. In vitro cytotoxic effects of benzalkonium chloride in corticosteroid injection suspension. J Bone Joint Surg Am. 2010;92:129–137.
    1. Douglas RJ. Corticosteroid injection into the osteoarthritic knee: drug selection, dose, and injection frequency. Int J Clin Pract. 2012;66:699–704.
    1. Dragoo JL, Danial CM, Braun HJ, Pouliot MA, Kim HJ. The chondrotoxicity of single-dose corticosteroids. Knee Surg Sports Traumatol Arthrosc. 2012;20:1809–1814.
    1. Farkas B, Kvell K, Czompoly T, Illes T, Bardos T. Increased chondrocyte death after steroid and local anesthetic combination. Clin Orthop Relat Res. 2010;468:3112–3120.
    1. Food and Drug Administration. FDA professional drug information. . Accessed April 2014.
    1. Frisbie DD, Kawcak CE, Trotter GW, Powers BE, Walton RM, McIlwraith CW. Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model. Equine Vet J. 1997;29:349–359.
    1. Gibson T, Burry HC, Poswillo D, Glass J. Effect of intra-articular corticosteroid injections on primate cartilage. Ann Rheum Dis. 1977;36:74–79.
    1. Godwin M, Dawes M. Intra-articular steroid injections for painful knees. Systematic review with meta-analysis. Can Fam Physician. 2004;50:241–248.
    1. Hameed F, Ihm J. Injectable medications for osteoarthritis. P M R. 2012;4(suppl):S75–S81.
    1. Huebner KD, Shrive NG, Frank CB. Dexamethasone inhibits inflammation and cartilage damage in a new model of post-traumatic osteoarthritis. J Orthop Res. 2014;32:566–572.
    1. Ishikawa K. Effect of intra-articular corticosteroid on the meniscus. A histological and histochemical study in rabbit knees. J Bone Joint Surg Am. 1981;63:120–130.
    1. Ishikawa K, Ohira T, Sakata H. Effects of intraarticular injection of halopredone diacetate on the articular cartilage of rabbit knees: a comparison with methylprednisolone acetate. Toxicol Appl Pharmacol. 1984;75:423–436.
    1. Kopta JA, Blosser JA. Elasticity of articular cartilage. Effects of intra-articular steroid administration and medial meniscectomy. Clin Orthop Relat Res. 1969;64:21–32.
    1. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
    1. Liu N, Wang W, Zhao Z, Zhang T, Song Y. Autophagy in human articular chondrocytes is cytoprotective following glucocorticoid stimulation. Mol Med Rep. 2014;9:2166–2172.
    1. Lutfi AM, Kosel K. Effects of intra-articularly administered corticosteroids and salicylates on the surface structure of articular cartilage. J Anat. 1978;127:393–402.
    1. Mankin HJ, Conger KA. The acute effects of intra-articular hydrocortisone on articular cartilage in rabbits. J Bone Joint Surg Am. 1966;48:1383–1388.
    1. Moskowitz RW, Davis W, Sammarco J, Mast W, Chase SW. Experimentally induced corticosteroid arthropathy. Arthritis Rheum. 1970;13:236–243.
    1. Murray RC, DeBowes RM, Gaughan EM, Zhu CF, Athanasiou KA. The effects of intra-articular methylprednisolone and exercise on the mechanical properties of articular cartilage in the horse. Osteoarthritis Cartilage. 1998;6:106–114.
    1. Oegema TR, Jr, Behrens F. Proteoglycan aggregate synthesis in normal and chronically hydrocortisone-suppressed rabbit articular cartilage. Arch Biochem Biophys. 1981;206:277–284.
    1. Pelletier JP, Martel-Pelletier J. Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum. 1989;32:181–193.
    1. Pelletier JP, Mineau F, Raynauld JP, Woessner JF, Jr, Gunja-Smith Z, Martel-Pelletier J. Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum. 1994;37:414–423.
    1. . United States pharmacopeia reference tables. . Accessed April 2014.
    1. Raynauld JP, Buckland-Wright C, Ward R, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2003;48:370–377.
    1. Salter RB, Gross A, Hall JH. Hydrocortisone arthropathy—an experimental investigation. Can Med Assoc J. 1967;97:374–377.
    1. Snibbe JC, Gambardella RA. Use of injections for osteoarthritis in joints and sports activity. Clin Sports Med. 2005;24:83–91.
    1. Song YW, Zhang T, Wang WB. Gluococorticoid could influence extracellular matrix synthesis through Sox9 via p38 MAPK pathway. Rheumatol Int. 2012;32:3669–3673.
    1. Su S, Dehnade F, Zafarullah M. Regulation of tissue inhibitor of metalloproteinases-3 gene expression by transforming growth factor-β and dexamethasone in bovine and human articular chondrocytes. DNA Cell Biol. 1996;15:1039–1048.
    1. Syed HM, Green L, Bianski B, Jobe CM, Wongworawat MD. Bupivacaine and triamcinolone may be toxic to human chondrocytes: a pilot study. Clin Orthop Relat Res. 2011;469:2941–2947.
    1. Tu Y, Xue H, Francis W, et al. Lactoferrin inhibits dexamethasone-induced chondrocyte impairment from osteoarthritic cartilage through up-regulation of extracellular signal-regulated kinase 1/2 and suppression of FASL, FAS, and Caspase 3. Biochem Biophys Res Commun. 2013;441:249–255.
    1. Tung JT, Venta PJ, Caron JP. Inducible nitric oxide expression in equine articular chondrocytes: effects of antiinflammatory compounds. Osteoarthritis Cartilage. 2002;10:5–12.
    1. Wang J, Elewaut D, Hoffman I, Veys EM, Verbruggen G. Physiological levels of hydrocortisone maintain an optimal chondrocyte extracellular matrix metabolism. Ann Rheum Dis. 2004;63:61–66.
    1. Wang L, Wang J, Almqvist KF, Veys EM, Verbruggen G. Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro. Clin Exp Rheumatol. 2002;20:669–676.
    1. Williams JM, Brandt KD. Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage. Arthritis Rheum. 1985;28:1267–1274.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner